References References TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial Retatrutide in patients with obesity and MASLD Body composition outcomes of Retatrutide in patients with obesity Retatrutide in type 2 diabetes efficacy and glucose response Sub-analysis of the Phase 2 trial in Nature Medicine ClinicalTrials.gov: Ongoing global studies on weight loss, cardiovascular risk, and diabetes outcomes Synonyms: Retatrutide, 2381089-83-2, EX-A7826E, GTPL13769 Research & background Independent, research-focused reading
Wegovy contains the same active ingredient as Ozempic, which is approved to treat type 2 diabetes
Common GLP-1 medications include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), tirzepatide (Mounjaro, Zepbound), and dulaglutide (Trulicity)
Alcohol can increase the risk of hypoglycemia, particularly in patients with diabetes who are also taking insulin or sulfonylureas in combination with semaglutide
The goal of these medications is to help you manage hunger and food noise, not eliminate it entirely